Skip to main content
. 2019 May 3;36(2):88–96. doi: 10.4274/tjh.galenos.2019.2018.0220

Table 3. Acute and chronic Graft-versus-host disease in patients treated with myeloablative conditioning and reduced-intensity conditioning regimens.

graphic file with name TJH-36-88-g3.jpg